Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration01:25

Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration

105
Hemoperfusion and hemofiltration are critical techniques in medical treatments to eliminate accumulated drugs, metabolites, and electrolytes from the bloodstream. These methods are particularly vital in cases of accidental poisoning and drug overdose.Hemoperfusion involves passing blood through an adsorbent material to remove unwanted substances. The main adsorbents used in hemoperfusion include activated charcoal and Amberlite resins. Activated charcoal can adsorb both polar and nonpolar...
105
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure01:16

Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure

481
Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
481
Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis01:30

Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis

215
Patients with end-stage renal disease (ESRD) or those experiencing drug overdose often require extracorporeal methods to eliminate accumulated drugs and metabolites. Hemoperfusion, hemofiltration, and dialysis are the primary techniques to rapidly remove harmful substances without disrupting the patient's fluid and electrolyte balance. For those with compromised renal function, dosage adjustments of concurrent medications may be necessary during extracorporeal drug removal.Dialysis is a process...
215
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

341
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
341

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Volumetric Capnography: The End of the Road?

Respiratory care·2025
Same author

A Proposed Component of an Extubation Readiness Bundle: Science or Marketing?

Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies·2025
Same author

Building Surgical Character: A Dynamic Simulation Curriculum for Nontechnical Skills.

Journal of surgical education·2025
Same author

Executive Summary: The Pediatric Extracorporeal Membrane Oxygenation Anticoagulation CollaborativE (PEACE) Consensus Conference.

Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies·2024
Same author

Management of Bleeding and Thrombotic Complications During Pediatric Extracorporeal Membrane Oxygenation: The Pediatric Extracorporeal Membrane Oxygenation Anticoagulation CollaborativE Consensus Conference.

Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies·2024
Same author

Priorities for Clinical Research in Pediatric Extracorporeal Membrane Oxygenation Anticoagulation From the Pediatric Extracorporeal Membrane Oxygenation Anticoagulation CollaborativE Consensus Conference.

Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies·2024

Related Experiment Video

Updated: Dec 13, 2025

Veno-Venous Extracorporeal Membrane Oxygenation in a Mouse
06:41

Veno-Venous Extracorporeal Membrane Oxygenation in a Mouse

Published on: October 24, 2018

12.8K

Extracorporeal Membrane Oxygenation for Hemodynamic Support.

Tobias Straube1, Ira M Cheifetz1, Kimberly W Jackson1

  • 1Pediatric Critical Care Medicine, Duke Children's, Durham, NC, USA.

Clinics in Perinatology
|July 28, 2020
PubMed
Summary

Extracorporeal membrane oxygenation (ECMO) has evolved since 1975 to support neonates with complex conditions, including cardiac issues and arrest. Advances enable ECMO for critical cases, excluding those with severe contraindications like extreme prematurity or irreversible brain injury.

Keywords:
Cardiac arrestCardiac shockCardiac surgeryCongenital heart diseaseExtracorporeal life supportExtracorporeal membrane oxygenation (ECMO)HypotensionHypoxemia

More Related Videos

Point-of-Care Ultrasound for Peripheral Veno-Arterial Extracorporeal Membrane Oxygenation Without Left Ventricular Venting
03:40

Point-of-Care Ultrasound for Peripheral Veno-Arterial Extracorporeal Membrane Oxygenation Without Left Ventricular Venting

Published on: January 17, 2025

636
Lung Rapid Recovery Procurement Combined with Abdominal Normothermic Regional Perfusion in Controlled Donation after Circulatory Death
09:54

Lung Rapid Recovery Procurement Combined with Abdominal Normothermic Regional Perfusion in Controlled Donation after Circulatory Death

Published on: August 15, 2022

2.2K

Related Experiment Videos

Last Updated: Dec 13, 2025

Veno-Venous Extracorporeal Membrane Oxygenation in a Mouse
06:41

Veno-Venous Extracorporeal Membrane Oxygenation in a Mouse

Published on: October 24, 2018

12.8K
Point-of-Care Ultrasound for Peripheral Veno-Arterial Extracorporeal Membrane Oxygenation Without Left Ventricular Venting
03:40

Point-of-Care Ultrasound for Peripheral Veno-Arterial Extracorporeal Membrane Oxygenation Without Left Ventricular Venting

Published on: January 17, 2025

636
Lung Rapid Recovery Procurement Combined with Abdominal Normothermic Regional Perfusion in Controlled Donation after Circulatory Death
09:54

Lung Rapid Recovery Procurement Combined with Abdominal Normothermic Regional Perfusion in Controlled Donation after Circulatory Death

Published on: August 15, 2022

2.2K

Area of Science:

  • Pediatric Critical Care Medicine
  • Neonatal Cardiology
  • Cardiopulmonary Support

Background:

  • Extracorporeal membrane oxygenation (ECMO) was first successful in 1975 for meconium aspiration in neonates.
  • Its application has broadened to include hemodynamic support for cardiovascular collapse, post-cardiac surgery, medical heart disease, and cardiac arrest rescue therapy.
  • Technological advancements in pumps, circuits, and oxygenators have enhanced ECMO's capability to manage complex neonatal pathophysiology.

Purpose of the Study:

  • To review the historical development and expanded applications of neonatal extracorporeal membrane oxygenation.
  • To highlight the technological advancements driving ECMO's efficacy in complex neonatal cases.
  • To outline the current contraindications and future directions for ECMO therapy.

Main Methods:

  • Literature review of historical and contemporary applications of neonatal ECMO.
  • Analysis of technological advancements influencing ECMO performance.
  • Identification of established contraindications and future research needs.

Main Results:

  • ECMO has evolved from treating meconium aspiration to supporting a wider range of critical neonatal conditions.
  • Improved technology has enabled ECMO to manage neonates with more severe and complex diseases.
  • Contraindications are clearly defined, including extreme prematurity, low birth weight, chromosomal abnormalities, hemorrhage, coagulopathy, and severe brain injury.

Conclusions:

  • Neonatal ECMO is a vital therapy supporting complex pediatric cases.
  • Continued collaboration is essential for developing evidence-based practices in ECMO.
  • Future efforts should focus on refining ECMO protocols and expanding its evidence base.